跳至主要内容
临床试验/TCTR20220121004
TCTR20220121004Unknown3 期

Effect of adding the second dose of sertaconazole 300mg vaginal ovule for treating pregnant women with acute vaginal candidiasis who were treated with a 300mg sertaconazole vaginal ovule: a randomized controlled trial

Pacific Health Care (Thailand)0 个研究点目标入组 110 人开始时间: 2022年1月21日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • 1.Age 18 and more years
  • 2.Pregnancy GA 20-34 weeks
  • 3.Diagnosis with vaginal candidiasis by microscope

排除标准

  • 1.Abnormal uterine bleeding or abnormal vaginal discharge
  • 2.Having at least 4 times in preceding year
  • 3.Contraindication for imidazole such as liver disease, allergy
  • 4.Cannot understand Thai
  • 5.Being treated with imidazole in preceding month
  • 6.Diabetes mellitus being on insulin
  • 7.Immunocompromised condition

研究者

发起方
Pacific Health Care (Thailand)

相似试验